Immunotherapy Biomarkers and Patient Selection episode artwork

EPISODE · Jan 19, 2016 · 24 MIN

Immunotherapy Biomarkers and Patient Selection

from GRACEcast · host cancerGRACE Meetings

Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melanoma.

Episode metadata supplied by the publisher feed · Published Jan 19, 2016

Embed this episode

NOW PLAYING

Immunotherapy Biomarkers and Patient Selection

0:00 24:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 24 minutes long.

When was this GRACEcast episode published?

This episode was published on January 19, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!